Dr. Vinay Prasad discusses the ongoing debate surrounding vaccine boosters, particularly in lower-risk groups such as young children and those who have recovered from COVID. He highlights the need for more data and larger trials to determine the effectiveness of additional doses. The discussion also delves into the potential risks and benefits associated with boosters, including the emergence of myocarditis as a safety signal.
